Nuclear Medicine and Biology 2010-05-01

Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU).

Harry Anderson, Nagavarakishore Pillarsetty, Melchor Cantorias, Jason S Lewis, Harry Anderson, Nagavarakishore Pillarsetty, Melchor Cantorias, Jason S Lewis, Harry Anderson, Nagavarakishore Pillarsetty, Melchor Cantorias, Jason S Lewis, Harry Anderson, Nagavarakishore Pillarsetty, Melchor Cantorias, Jason S Lewis, Harry Anderson, NagaVaraKishore Pillarsetty, Melchor Cantorias, Jason S. Lewis

文献索引：Nucl. Med. Biol. 37(4) , 439-42, (2010)

全文：HTML全文

摘要

An improved synthesis of 2'-[(18)F]-fluoro-2'-deoxy-1-beta-D-arabinofuranosyl-5-iodouracil ([(18)F]-FIAU) has been developed. The method utilizes trimethylsilyl trifluoromethanesulfonate (TMSOTf) catalyzed coupling of 2-deoxy-2-[(18)F]-fluoro-1,3,5-tri-O-benzoyl-d-arabinofuranose with 2,4-bis(trimethylsilyloxy)-5-iodouracil to yield the protected dibenzoyl-[(18)F]-FIAU. Dibenzoyl-[(18)F]-FIAU was deprotected with sodium methoxide to yield a mixture of alpha- and beta-anomers in a ratio of 1:1, which were purified by HPLC. The procedure described in this article eliminates the need for HBr activation of the sugar prior to coupling with silylated iodouracil and is suitable for automation. The total reaction time was about 110 min, starting from [(18)F]-fluoride. The average isolated yield of the required beta-anomer was 10+/-6% (decay corrected) with average specific activity of 125 mCi/micromol.(c) 2010 Elsevier Inc. All rights reserved.